海利生物:控股股東上海豪園持股降至43.5356%
格隆匯2月10日丨海利生物(603718.SH)公佈,2020年2月10日,公司再次收到上海豪園的換股情況通知,上海豪園作為公司控股股東於2020年2月3日至2月7日由於可交換債換股導致的權益變動累計超過1%,具體如下:
2020年2月3日至2020年2月7日,上海豪園在此期間的可交換債累計換股為約667.74萬股,佔海利生物總股本的1.0368%,換股價格為12.43元/股。截至2020年2月7日“17豪園EB”債券餘額為3300萬元。此次換股前,上海豪園持有公司股份數2.87億股,佔公司總股本的44.5724%;此次換股後,上海豪園持有公司股份2.8億股,佔公司總股本的43.5356%。公司控股股東及實際控制人未發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.